Found 27 matching trials
Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma PHASE2 This is a Phase II clinical trial for Decitabine plus Camrelizumab resistan...
Show More Location
Biotherapeutic Department of Chinese PLA General Hospital
Learn More & Join Trial
Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell Lymphoma PHASE2 The optimal first-line treatment for extra-nodal NK/T-cell lymphoma (ENKTL)...
Show More Location
National Cancer Center/Cancer Hosptial, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade N/A The combination of azacitidine and venetoclax is currently considered a the...
Show More Location
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Learn More & Join Trial
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC PHASE2 This study is being done because both 5-azacytidine and nivolumab can influ...
Show More Learn More & Join Trial
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT NA This study aims to evaluate the efficacy and safety of PD-1 inhibitor, Azac...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma PHASE2 Young patients with relapsed or refractory classic Hodgkin's lymphoma will ...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma PHASE2 This is an open-label, Phase 2/3,multicenter and single-arm clinical trial ...
Show More Location
Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital
Learn More & Join Trial
Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma PHASE2 The goal of this phase 2 trial is to test the safety and efficacy of azacit...
Show More Location
Navy General Hospital
Learn More & Join Trial
Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies) PHASE2 This study investigates the efficacy and safety of sintilimab in combinatio...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma. EARLY_PHASE1 An Open-Label, Single-Arm, Multicenter Phase II Clinical Study to Evaluate ...
Show More Location
The Second Affiliated Hospital of Soochow University Suzhou
Learn More & Join Trial